Roderick Slieker was born on the 1st of November 1986 in Veenendaal. From 2005 to 2009 he studied Pharmaceutical Sciences at the University of Utrecht. In 2009, he obtained his Bachelor’s degree after which he started the research master Drug Innovation. In 2011, he started his PhD at the Molecular Epidemiology section (Department of Medical Statistics a Bioinformatics, Leiden University) under supervision of prof.dr. Slagboom and dr. Heijmans. His research during his PhD focused on the mapping of DNA methylation dynamics during the human lifespan, from changes during early development to the changes that occur during the ageing process. Currently, he works as a postdoctoral researcher at the VUmc (Epidemiology and Biostatistics) and LUMC (Molecular Cell Biology). He works on the IMI project RHAPSODY and investigates the use of -omics techniques in the prediction of disease progression in type 2 diabetes.